abstract |
The present invention relates to a pharmaceutical formulation comprising a protein and free methionine in combination with one or more compounds capable of preventing the oxidation of aromatic amino acid residues in the protein. More specifically, the present invention relates to a stabilized pharmaceutically effective formulation of an oxidation sensitive therapeutic agent. The invention further relates to a method of preventing the oxidation of such therapeutic agents. |